EMA considerations on COVID-19 vaccine approval

This document provides guidance for developers of potential COVID-19 vaccines on the clinical evidence to include in marketing authorisation applications.

Keywords: COVID-19, SARS-CoV-2, vaccine, clinical requirements, clinical efficacy, clinical safety

How useful was this page?

Add your rating
Average
1 rating
1 rating